<?xml version="1.0"?>
 <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
   <id>647b07f0-223b-440c-8f19-6d3b6d6b2e73</id>
   <name>Antipruritics for Spinal/Epidural Anesthesia Adult Smart Group</name>
   <description>
     <lifecycle_state>Initial</lifecycle_state>
     <details>
       <purpose/>
       <use/>
       <misuse/>
     </details>
     <other_details>
       <item>
         <key>MetaDataSet:Sample Set </key>
         <value>Template metadata sample set </value>
       </item>
       <item>
         <key>Acknowledgements</key>
         <value/>
       </item>
       <item>
         <key>Business Process Level</key>
         <value/>
       </item>
       <item>
         <key>Care setting</key>
         <value/>
       </item>
       <item>
         <key>Client group</key>
         <value/>
       </item>
       <item>
         <key>Clinical Record Element</key>
         <value/>
       </item>
       <item>
         <key>Copyright</key>
         <value/>
       </item>
       <item>
         <key>Issues</key>
         <value/>
       </item>
       <item>
         <key>Owner</key>
         <value/>
       </item>
       <item>
         <key>Sign off</key>
         <value/>
       </item>
       <item>
         <key>Speciality</key>
         <value/>
       </item>
       <item>
         <key>User roles</key>
         <value/>
       </item>
     </other_details>
   </description>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
     <items>
       <item>
         <key>Technical.ï»© Technical Traceability</key>
         <value>{~AHSID~647b07f0-223b-440c-8f19-6d3b6d6b2e73~NAME~Antipruritics for Spinal/Epidural Anesthesia Adult Smart Group}</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;naloxone injection&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;em&gt;For naloxone, recommended standard dosing is 0.02 to 0.04 mg. &lt;/em&gt;&lt;/p&gt;</value>
       </item>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;0.02 mg, intravenous, every 2 hours, as needed, opioid-induced pruritis&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;nalbuphine injection&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;em&gt;Nalbuphine may cause sedation and/or respiratory depression in the elderly (over the age of 60). Consider limiting the dose to 2.5 mg every 3 hours or use IV naloxone instead. &lt;/em&gt;&lt;/p&gt;</value>
       </item>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;2.5 mg, intravenous, every 3 hours, as needed, opioid-induced pruritis&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;diphenhydrAMINE injection&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;em&gt;For diphenhydramine, recommended standard dosing is 10 to 50 mg. Maximum daily dose 400 mg.&lt;/em&gt;&lt;/p&gt;</value>
       </item>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;25 mg, intravenous, every 4 hours, as needed, pruritis&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Antipruritics (OSQ 232819) ">
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="63f47fa1-0b8a-4624-8769-9ec68ce14421" concept_name="PHARM naloxone injection Order" max="1" path="/items" name="naloxone injection"/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a10737b8-610b-4e26-a6e2-7e89a5c80ee4" concept_name="PHARM nalbuphine injection Order" max="1" path="/items" name="nalbuphine injection"/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df7f878b-85c0-47ce-a50e-531ca3963b40" concept_name="PHARM diphenhydrAMINE injection Order" max="1" path="/items" name="diphenhydrAMINE injection"/>
   </definition>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
   </integrity_checks>
 </template>